Inebilizumab reduces neuromyelitis optica spectrum disorder risk independent of FCGR3A polymorphism
Article in Annals of Clinical and Translational Neurology (October 2023)
The most recent citing publications are shown below. View all 37 publications that cite this research output on Dimensions.
Article in Annals of Clinical and Translational Neurology (October 2023)
Article in The Pharmacogenomics Journal (May 2023)
Article in International Journal of Rheumatic Diseases (April 2023)